Clinical Trials

Status
Published

Recently Activated

SHOW MORE

Active Filters

    Open
    Accrual
    0%
    SWOG Clinical Trial Number
    S1934
    Open
    Phase
    II
    Accrual
    0%
    SWOG Clinical Trial Number
    S2013

    Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

    Status Notes
    S2013 will open to accrual on August 16, 2021, effective 12:00 pm PST.
    Research Committee(s)
    Symptom Control and Quality of Life
    Activated
    08-16-2021
    Open
    Accrual
    0%
    SWOG Clinical Trial Number
    S1912CD

    A Randomized Trial Addressing Cancer-Related Financial Hardship Through Delivery of a Proactive Financial Navigation Intervention (CREDIT)

    Status Notes
    Activation - Effective 2:00 p.m. Eastern Time.

    All protocol documents will be accessible from the S1912CD protocol abstract page on www.ctsu.org after activation on 7/26/2021(login required).
    Research Committee(s)
    Cancer Care Delivery
    Activated
    07-26-2021
    ClinicalTrials.gov Registry Number
    NCT 04960787
    Open
    Phase
    Accrual
    0%
    SWOG Clinical Trial Number
    S2005
    Open
    Phase
    III
    SWOG Clinical Trial Number
    CTSU/NRG-BR007

    A Phase III Clinical Trial Evaluating De-escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score </= 18 Breast Cancer

    Status Notes
    CTSU/NRG-BR007 has been endorsed and activated by SWOG, effective 6/15/2021. CTSU/NRG-BR007 was activated by NRG Oncology, effective 6/7/21.
    Research Committee(s)
    Breast Cancer
    Activated
    06-07-2021
    ClinicalTrials.gov Registry Number
    04852887
    Open
    Phase
    SWOG Clinical Trial Number
    CTSU/ANHL1931

    A Randomized Phase 3 trial of Nivolumab (NSC# 748726 IND# 125462) in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma.

    Status Notes
    CTSU/ANHL1931 was temporarily closed to accrual on 6/24/21.
    CTSU/ANHL1931 has been endorsed and activated by SWOG, effective 7/15/21. CTSU/ANHL1931 was activated by Children's Oncology Group, effective 6/7/21.
    Research Committee(s)
    Lymphoma
    Activated
    06-07-2021
    ClinicalTrials.gov Registry Number
    04759586